PF-04360365 10 mg/kg

BIOLOGICAL2 trials

Sponsors

Pfizer

Conditions

Alzheimer's Disease

Phase 1

Single Dose Escalation Study of PF-04360365 In Subjects With Mild To Moderate Alzheimer's Disease

CompletedNCT00733642

PfizerAlzheimer's Disease

Start: 2008-08-31End: 2009-07-31Updated: 2009-07-28

Phase 2

A Multiple Dose Study of PF-04360365 In Patients With Mild to Moderate Alzheimer's Disease

CompletedNCT00945672

PfizerAlzheimer's Disease

Start: 2009-08-06End: 2011-06-01Updated: 2024-04-19